<VariationArchive VariationID="132109" VariationName="NM_015713.5(RRM2B):c.253_255del (p.Glu85del)" VariationType="Deletion" Accession="VCV000132109" Version="11" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-07-29" DateCreated="2015-03-24" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="136331" VariationID="132109">
      <GeneList>
        <Gene Symbol="RRM2B" FullName="ribonucleotide reductase regulatory TP53 inducible subunit M2B" GeneID="50484" HGNC_ID="HGNC:17296" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="102204501" stop="102238961" display_start="102204501" display_stop="102238961" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="103216728" stop="103251345" display_start="103216728" display_stop="103251345" Strand="-" />
          </Location>
          <OMIM>604712</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_015713.5(RRM2B):c.253_255del (p.Glu85del)</Name>
      <CanonicalSPDI>NC_000008.11:102225983:CTC:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="102225984" stop="102225986" display_start="102225984" display_stop="102225986" variantLength="3" positionVCF="102225983" referenceAlleleVCF="TCTC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="103238212" stop="103238214" display_start="103238212" display_stop="103238214" variantLength="3" positionVCF="103238211" referenceAlleleVCF="TCTC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>E33del</ProteinChange>
      <ProteinChange>E157del</ProteinChange>
      <ProteinChange>E85del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.103238212_103238214del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.103238212_103238214del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.102225984_102225986del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.102225984_102225986del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016617.1" sequenceAccession="NG_016617" sequenceVersion="1" change="g.18133_18135del">
            <Expression>NG_016617.1:g.18133_18135del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172477.1" sequenceAccession="NM_001172477" sequenceVersion="1" change="c.469_471del">
            <Expression>NM_001172477.1:c.469_471del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165948.1" sequenceAccession="NP_001165948" sequenceVersion="1" change="p.Glu157del">
            <Expression>NP_001165948.1:p.Glu157del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172478.2" sequenceAccession="NM_001172478" sequenceVersion="2" change="c.97_99del">
            <Expression>NM_001172478.2:c.97_99del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165949.1" sequenceAccession="NP_001165949" sequenceVersion="1" change="p.Glu33del">
            <Expression>NP_001165949.1:p.Glu33del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015713.5" sequenceAccession="NM_015713" sequenceVersion="5" change="c.253_255del" MANESelect="true">
            <Expression>NM_015713.5:c.253_255del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056528.2" sequenceAccession="NP_056528" sequenceVersion="2" change="p.Glu85del">
            <Expression>NP_056528.2:p.Glu85del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_788" sequenceAccession="LRG_788">
            <Expression>LRG_788:g.18133_18135del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_788t1" sequenceAccession="LRG_788t1">
            <Expression>LRG_788t1:c.469_471del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_788p1" sequenceAccession="LRG_788p1" change="p.Glu157del">
            <Expression>LRG_788p1:p.Glu157del</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015713.4" sequenceAccession="NM_015713" sequenceVersion="4" change="c.253_255delGAG">
            <Expression>NM_015713.4:c.253_255delGAG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015713.4" sequenceAccession="NM_015713" sequenceVersion="4" change="c.253_255del">
            <Expression>NM_015713.4:c.253_255del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA204014" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="604712.0004" DB="OMIM" />
        <XRef Type="rs" ID="515726184" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00002" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015713.5(RRM2B):c.253_255del (p.Glu85del) AND Mitochondrial DNA depletion syndrome 8a" Accession="RCV000005720" Version="11">
        <ClassifiedConditionList TraitSetID="6232">
          <ClassifiedCondition DB="MedGen" ID="C2749861">Mitochondrial DNA depletion syndrome 8a</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-06-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015713.5(RRM2B):c.253_255del (p.Glu85del) AND RRM2B-related mitochondrial disease" Accession="RCV000118988" Version="12">
        <ClassifiedConditionList TraitSetID="13737">
          <ClassifiedCondition DB="MedGen" ID="CN187502">RRM2B-related mitochondrial disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015713.5(RRM2B):c.253_255del (p.Glu85del) AND Idiopathic camptocormia" Accession="RCV000186558" Version="9">
        <ClassifiedConditionList TraitSetID="22128">
          <ClassifiedCondition DB="MedGen" ID="C0264162">Idiopathic camptocormia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2013-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015713.5(RRM2B):c.253_255del (p.Glu85del) AND not provided" Accession="RCV000413797" Version="15">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2024-01-18" SubmissionCount="2">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015713.5(RRM2B):c.253_255del (p.Glu85del) AND multiple conditions" Accession="RCV002483199" Version="8">
        <ClassifiedConditionList TraitSetID="82021">
          <ClassifiedCondition DB="MedGen" ID="C2749861">Mitochondrial DNA depletion syndrome 8a</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2751319">Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1849333">Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-14" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-18" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2015-03-24" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Likely pathogenic(2); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">17486094</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21378381</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31521625</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">24741716</ID>
          <ID Source="BookShelf">NBK195854</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Likely pathogenic(2); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2024-02-11">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-05-29">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-01-07">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="13737" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="18761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">RRM2B-related mitochondrial disease</ElementValue>
              </Name>
              <XRef ID="CN187502" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="22128" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="13448" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Idiopathic camptocormia</ElementValue>
                <XRef ID="MONDO:0015271" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Camptocormism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Camptocormia</ElementValue>
                <XRef ID="HP:0100595" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bent spine</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bent Spine Syndrome</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1063" />
                <XRef ID="1063" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1320" DB="Orphanet" />
              <XRef ID="C0264162" DB="MedGen" />
              <XRef ID="MONDO:0015271" DB="MONDO" />
              <XRef Type="primary" ID="HP:0100595" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="82021" Type="TraitChoice" ContributesToAggregateClassification="true">
            <Trait ID="3629" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction</ElementValue>
                <XRef ID="MONDO:0010000" DB="MONDO" />
              </Name>
              <XRef ID="C1849333" DB="MedGen" />
              <XRef ID="MONDO:0010000" DB="MONDO" />
              <XRef Type="MIM" ID="268315" DB="OMIM" />
            </Trait>
            <Trait ID="6823" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">RRM2B-Related Chronic Progressive External Ophthalmoplegia with Multiple mtDNA Deletions</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5</ElementValue>
                <XRef ID="MONDO:0013117" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT 5</ElementValue>
                <XRef Type="MIM" ID="613077" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chronic Progressive External Ophthalmoplegia with Multiple mtDNA Deletions</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PEOA5</ElementValue>
                <XRef Type="MIM" ID="613077" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16501" />
                <XRef ID="16501" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Four phenotypes comprise the RRM2B mitochondrial DNA maintenance defects (RRM2B-MDMDs): RRM2B encephalomyopathic MDMD, the most severe phenotype, usually manifesting shortly after birth as hypotonia, poor feeding, and faltering growth requiring hospitalization. Subsequent assessments are likely to reveal multisystem involvement including sensorineural hearing loss, renal tubulopathy, and respiratory failure. Autosomal dominant progressive external ophthalmoplegia (adPEO), typically adult onset; other manifestations can include ptosis, bulbar dysfunction, fatigue, and muscle weakness. RRM2B autosomal recessive progressive external ophthalmoplegia (arPEO), a typically childhood-onset predominantly myopathic phenotype of PEO, ptosis, proximal muscle weakness, and bulbar dysfunction. RRM2B mitochondrial neurogastrointestinal encephalopathy (MNGIE)-like, characterized by progressive ptosis, ophthalmoplegia, gastrointestinal dysmotility, cachexia, and peripheral neuropathy. To date, 78 individuals from 52 families with a molecularly confirmed RRM2B-MDMD have been reported.</Attribute>
                <XRef ID="NBK195854" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24741716</ID>
                <ID Source="BookShelf">NBK195854</ID>
              </Citation>
              <XRef ID="C2751319" DB="MedGen" />
              <XRef ID="MONDO:0013117" DB="MONDO" />
              <XRef Type="MIM" ID="613077" DB="OMIM" />
            </Trait>
            <Trait ID="2810" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC, WITH RENAL TUBULOPATHY, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="612075" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)</ElementValue>
                <XRef Type="MIM" ID="612075" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604712.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604712.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604712.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604712.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604712.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604712.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604712.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mitochondrial DNA depletion syndrome 8a</ElementValue>
                <XRef ID="MONDO:0012792" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mitochondrial DNA depletion syndrome, encephalomyopathic form, with renal tubulopathy</ElementValue>
                <XRef ID="Mitochondrial+DNA+depletion+syndrome%2C+encephalomyopathic+form%2C+with+renal+tubulopathy/8900" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MTDPS8A</ElementValue>
                <XRef Type="MIM" ID="612075" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">RRM2B-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form, with Renal Tubulopathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Four phenotypes comprise the RRM2B mitochondrial DNA maintenance defects (RRM2B-MDMDs): RRM2B encephalomyopathic MDMD, the most severe phenotype, usually manifesting shortly after birth as hypotonia, poor feeding, and faltering growth requiring hospitalization. Subsequent assessments are likely to reveal multisystem involvement including sensorineural hearing loss, renal tubulopathy, and respiratory failure. Autosomal dominant progressive external ophthalmoplegia (adPEO), typically adult onset; other manifestations can include ptosis, bulbar dysfunction, fatigue, and muscle weakness. RRM2B autosomal recessive progressive external ophthalmoplegia (arPEO), a typically childhood-onset predominantly myopathic phenotype of PEO, ptosis, proximal muscle weakness, and bulbar dysfunction. RRM2B mitochondrial neurogastrointestinal encephalopathy (MNGIE)-like, characterized by progressive ptosis, ophthalmoplegia, gastrointestinal dysmotility, cachexia, and peripheral neuropathy. To date, 78 individuals from 52 families with a molecularly confirmed RRM2B-MDMD have been reported.</Attribute>
                <XRef ID="NBK195854" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13200" />
                <XRef ID="13200" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24741716</ID>
                <ID Source="BookShelf">NBK195854</ID>
              </Citation>
              <XRef ID="255235" DB="Orphanet" />
              <XRef ID="C2749861" DB="MedGen" />
              <XRef ID="MONDO:0012792" DB="MONDO" />
              <XRef Type="MIM" ID="612075" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6232" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="2810" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC, WITH RENAL TUBULOPATHY, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="612075" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)</ElementValue>
                <XRef Type="MIM" ID="612075" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604712.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604712.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604712.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604712.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604712.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604712.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="604712.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mitochondrial DNA depletion syndrome 8a</ElementValue>
                <XRef ID="MONDO:0012792" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mitochondrial DNA depletion syndrome, encephalomyopathic form, with renal tubulopathy</ElementValue>
                <XRef ID="Mitochondrial+DNA+depletion+syndrome%2C+encephalomyopathic+form%2C+with+renal+tubulopathy/8900" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MTDPS8A</ElementValue>
                <XRef Type="MIM" ID="612075" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">RRM2B-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form, with Renal Tubulopathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Four phenotypes comprise the RRM2B mitochondrial DNA maintenance defects (RRM2B-MDMDs): RRM2B encephalomyopathic MDMD, the most severe phenotype, usually manifesting shortly after birth as hypotonia, poor feeding, and faltering growth requiring hospitalization. Subsequent assessments are likely to reveal multisystem involvement including sensorineural hearing loss, renal tubulopathy, and respiratory failure. Autosomal dominant progressive external ophthalmoplegia (adPEO), typically adult onset; other manifestations can include ptosis, bulbar dysfunction, fatigue, and muscle weakness. RRM2B autosomal recessive progressive external ophthalmoplegia (arPEO), a typically childhood-onset predominantly myopathic phenotype of PEO, ptosis, proximal muscle weakness, and bulbar dysfunction. RRM2B mitochondrial neurogastrointestinal encephalopathy (MNGIE)-like, characterized by progressive ptosis, ophthalmoplegia, gastrointestinal dysmotility, cachexia, and peripheral neuropathy. To date, 78 individuals from 52 families with a molecularly confirmed RRM2B-MDMD have been reported.</Attribute>
                <XRef ID="NBK195854" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13200" />
                <XRef ID="13200" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24741716</ID>
                <ID Source="BookShelf">NBK195854</ID>
              </Citation>
              <XRef ID="255235" DB="Orphanet" />
              <XRef ID="C2749861" DB="MedGen" />
              <XRef ID="MONDO:0012792" DB="MONDO" />
              <XRef Type="MIM" ID="612075" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="444454" SubmissionDate="2015-06-24" DateLastUpdated="2015-07-28" DateCreated="2015-07-28">
        <ClinVarSubmissionID localKey="Cytogenetic location: 8q22.3 Genomic coordinates (GRCh37): 8:103,216,728-103,251,345 (NCBI)" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000240100" DateUpdated="2015-07-28" DateCreated="2015-07-28" Type="SCV" Version="1" SubmitterName="Department of Neurology, University Hospital of Strasbourg" OrgID="505485" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Ethnicity>Caucasians</Ethnicity>
              <GeographicOrigin>France</GeographicOrigin>
              <Tissue>Muscle</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">70</Age>
              <Age Type="maximum" age_unit="years">79</Age>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
              <FamilyData NumFamilies="1" NumFamiliesWithVariant="1">
                <FamilyHistory>yes</FamilyHistory>
              </FamilyData>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Camptocormia</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Camptocormia</ElementValue>
                </Name>
              </Trait>
            </TraitSet>
            <Citation>
              <ID Source="PubMed">21378381</ID>
            </Citation>
            <Citation>
              <ID Source="PubMed">17486094</ID>
            </Citation>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RRM2B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015713.4:c.253_255delGAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Camptocormia</ElementValue>
            </Name>
          </Trait>
          <Comment>Myopathy (camptocormia)</Comment>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="25902" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604712.0004_MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)" title="RRM2B, 3-BP DEL, 253GAG_MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)" />
        <ClinVarAccession Accession="SCV000025902" DateUpdated="2021-01-01" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a French infant with severe mitochondrial DNA depletion with renal tubulopathy (612075), Bourdon et al. (2007) identified compound heterozygosity for 2 mutations in the RRM2B gene: a 3-bp deletion (253delGAG), resulting in an in-frame deletion of glu85, and C236F (604712.0005). The patient had neonatal hypotonia and increased plasma and CSF lactate; she died at age 3 months. Muscle histology showed ragged-red fibers, and mtDNA content was about 1% of normal. The deletion of glu85 was predicted to disrupt the local subdomain structure and the dimerization interface between R1 and R2.</Attribute>
              <Citation>
                <ID Source="PubMed">17486094</ID>
              </Citation>
              <XRef DB="OMIM" ID="612075" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RRM2B" />
          </GeneList>
          <Name>RRM2B, 3-BP DEL, 253GAG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, 253GAG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604712.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="278477" SubmissionDate="2021-08-23" DateLastUpdated="2022-10-01" DateCreated="2014-05-31">
        <ClinVarSubmissionID localKey="NM_015713.4:c.253_255delGAG|MedGen:CN187502" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000153686" DateUpdated="2022-10-01" DateCreated="2014-05-31" Type="SCV" Version="4" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation Type="general">
            <ID Source="BookShelf">NBK195854</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015713.4:c.253_255delGAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN187502" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Abbrev="GeneReviews" Type="review">
          <ID Source="PubMed">24741716</ID>
          <ID Source="BookShelf">NBK195854</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB10237106</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5446313" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_015713.5:c.253_255del|OMIM:268315;612075;613077" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002795122" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015713.5:c.253_255del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="268315" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612075" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613077" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="958657" SubmissionDate="2022-02-09" DateLastUpdated="2023-03-04" DateCreated="2017-01-09">
        <ClinVarSubmissionID localKey="GDXSV:221088" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000491112" DateUpdated="2023-03-04" DateCreated="2017-01-09" Type="SCV" Version="5" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Reported previously in trans with a missense variant in an infant with severe mitochondrial depletion (Bourdon et al., 2007); Reported previously in the heterozygous state in two adults with late-onset progressive external ophthalmoplegia (Pitceathly et al., 2011; Heighton et al., 2019); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed at a significant frequency in large population cohorts (gnomAD); In-frame deletion of 1 amino acid in a non-repeat region; This variant is associated with the following publications: (PMID: 21378381, 17486094, 31521625, 29241262, 33300680)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RRM2B" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:640511</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015713.4:c.253_255del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_16_20210716195449</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_87_20220209054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7980136" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4877393|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004295250" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21378381</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31521625</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17486094</ID>
          </Citation>
          <Comment>This variant, c.253_255del, results in the deletion of 1 amino acid(s) of the RRM2B protein (p.Glu85del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs515726184, gnomAD 0.002%). This variant has been observed in individuals with clinical features of autosomal dominant progressive external ophthalmoplegia (PMID: 21378381, 31521625; Invitae). This variant has been reported in individual(s) with autosomal recessive mitochondrial DNA depletion syndrome (PMID: 17486094); however, the role of the variant in this condition is currently unclear. ClinVar contains an entry for this variant (Variation ID: 132109). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RRM2B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.103238212_103238214del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="25902" TraitType="Disease" MappingType="Name" MappingValue="MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)" MappingRef="Preferred">
        <MedGen CUI="C2749861" Name="Mitochondrial DNA depletion syndrome 8a" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446313" TraitType="Disease" MappingType="XRef" MappingValue="613077" MappingRef="OMIM">
        <MedGen CUI="C2751319" Name="Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446313" TraitType="Disease" MappingType="XRef" MappingValue="612075" MappingRef="OMIM">
        <MedGen CUI="C2749861" Name="Mitochondrial DNA depletion syndrome 8a" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7980136" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="444454" TraitType="Disease" MappingType="Name" MappingValue="Camptocormia" MappingRef="Preferred">
        <MedGen CUI="C0264162" Name="Idiopathic camptocormia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="958657" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5446313" TraitType="Disease" MappingType="XRef" MappingValue="268315" MappingRef="OMIM">
        <MedGen CUI="C1849333" Name="Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="444454" TraitType="Finding" MappingType="Name" MappingValue="Camptocormia" MappingRef="Preferred">
        <MedGen CUI="C0264162" Name="Idiopathic camptocormia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="278477" TraitType="Disease" MappingType="XRef" MappingValue="CN187502" MappingRef="MedGen">
        <MedGen CUI="CN187502" Name="RRM2B-related mitochondrial disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

